{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(3)"],"submitter":["Shen N"],"journal":["RMD open"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12352177"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study"],"pmcid":["PMC12352177"],"pubmed_authors":["Sips C","Gergely P","Weinmann-Menke J","Danekula R","Shen N","Serra-Roma A","Felten R","Shisha T","Rohr J","Weiss M","Malvar A"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Jan","modification":"2026-05-29T15:08:36.994Z","creation":"2026-04-08T05:11:55.94Z"},"accession":"S-EPMC12352177","cross_references":{}}